You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Brentuximab vedotin

Showing 251 - 275 of 296
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Hodgkin Lymphoma Trial in Worldwide (Epcoritamab, Lenalidomide, Ibrutinib)

Recruiting
  • Non-Hodgkin Lymphoma
  • Tucson, Arizona
  • +81 more
Jan 25, 2023

Diffuse Large B Cell Lymphoma, Mediastinal Large B-cell Lymphoma, Grey Zone Lymphoma Trial in Tucson (Brentuximab, Bendamustine,

Withdrawn
  • Diffuse Large B Cell Lymphoma
  • +6 more
  • Tucson, Arizona
    Arizona Cancer Center at UMC North
May 18, 2017

Primary Mediastinal Large B Cell Lymphoma Trial in Italy (Brentuximab Vedotin)

Completed
Has Results
  • Primary Mediastinal Large B Cell Lymphoma
  • Brentuximab Vedotin
  • Alessandria, AL, Italy
  • +8 more
Apr 10, 2017

B-Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Worldwide (Glofitamab, Obinutuzumab (G), Rituximab (R))

Active, not recruiting
  • B-Cell Lymphoma
  • Non-Hodgkin Lymphoma
  • Birmingham, Alabama
  • +23 more
Dec 2, 2022

Recurrent Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in United States (Glembatumumab Vedotin, Laboratory Biomarker

Completed
Has Results
  • Recurrent Uveal Melanoma
  • Stage IV Uveal Melanoma AJCC v7
  • Glembatumumab Vedotin
  • +2 more
  • Phoenix, Arizona
  • +24 more
Jul 30, 2020

DLBCL, Diffuse Large B Cell Lymphoma Trial in Worldwide (R-pola-mini-CHP, R-mini-CHOP)

Recruiting
  • DLBCL
  • Diffuse Large B Cell Lymphoma
  • Aalborg, Denmark
  • +44 more
Jul 8, 2021

Non-Hodgkin Lymphoma (NHL), Cutaneous Lymphoma, Cutaneous T-cell Lymphoma (CTCL) Trial in Stanford (Brentuximab vedotin)

Completed
Has Results
  • Non-Hodgkin Lymphoma (NHL)
  • +4 more
  • Brentuximab vedotin
  • Stanford, California
    Stanford University School of Medicine
Feb 17, 2017

Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (Venetoclax, Polatuzumab Vedotin, Rituximab)

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • New York, New York
  • +19 more
Aug 17, 2022

Follicular Lymphoma, DLBCL Trial in Worldwide (Obinutuzumab, Pinatuzumab Vedotin, Polatuzumab Vedotin)

Completed
Has Results
  • Follicular Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • Los Angeles, California
  • +40 more
Feb 20, 2020

Lymphoma, Hodgkin's Lymphoma, Non-hodgkin's Lymphoma Trial in Goodyear (Pembrolizumab, Etoposide, Ifosfamide)

Withdrawn
  • Lymphoma
  • +2 more
  • Goodyear, Arizona
    Cancer Treatment Center of America @ Western Regional Medical Ce
Jun 23, 2017

Lymphoma, Non Hodgkin Trial in France, United States (Cyclophosphamide, Doxorubicin, Obinutuzumab)

Completed
Has Results
  • Lymphoma, Non Hodgkin
  • Birmingham, Alabama
  • +10 more
Feb 18, 2020

Peripheral T-Cell Lymphoma Trial in Tampa (Brentuximab vedotin)

Terminated
Has Results
  • Peripheral T-Cell Lymphoma
  • Brentuximab vedotin
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 22, 2016

Metastatic Urothelial Cancer Trial in Japan (Enfortumab vedotin)

Completed
  • Metastatic Urothelial Cancer
  • Enfortumab vedotin
  • Tsukuba, Ibaraki, Japan
  • +7 more
Mar 2, 2020

Study to Evaluate Effectiveness and Safety of Polatuzumab

Unknown status
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Polatuzumab Vedotin-Piiq
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Nov 10, 2020

Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in France, United States (brentuximab vedotin)

Completed
Has Results
  • Disease, Hodgkin
  • +2 more
  • brentuximab vedotin
  • Birmingham, Alabama
  • +16 more
Dec 7, 2016

Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

Completed
Has Results
  • Lymphoma, Large-Cell, Anaplastic
  • Lymphoma, Non-Hodgkin
  • brentuximab vedotin
  • Birmingham, Alabama
  • +21 more
Feb 2, 2017

Locally Advanced or Metastatic Urothelial Carcinoma (UC) Trial in United States (enfortumab vedotin (EV))

Approved for marketing
  • Locally Advanced or Metastatic Urothelial Carcinoma (UC)
  • enfortumab vedotin (EV)
  • Los Angeles, California
  • +14 more
Jan 9, 2020

Lymphoma, T-Cell, Peripheral Trial (Romidepsin, Pralatrexate)

Withdrawn
  • Lymphoma, T-Cell, Peripheral
  • (no location specified)
Dec 17, 2018

Non Small Cell Lung Cancer Trial in Guangzhou (Nivolumab, carboplatin, nab-paclitaxel)

Recruiting
  • Non Small Cell Lung Cancer
  • Nivolumab
  • +2 more
  • Guangzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong General Hospital, Gua
Feb 11, 2020

Disease, Hodgkin Trial in Worldwide (brentuximab vedotin)

Completed
Has Results
  • Disease, Hodgkin
  • brentuximab vedotin
  • Birmingham, Alabama
  • +26 more
Mar 9, 2017

Squamous Cell Carcinoma of the Lung Trial in United States (Phase I: Glembatumumab Vedotin, Phase II: Glembatumumab Vedotin)

Terminated
Has Results
  • Squamous Cell Carcinoma of the Lung
  • Phase I: Glembatumumab Vedotin
  • Phase II: Glembatumumab Vedotin
  • Miami, Florida
  • +9 more
Jun 21, 2019

Melanoma Trial in United States (glembatumumab vedotin, glembatumumab vedotin and varlilumab, glembatumumab vedotin and PD-1

Terminated
Has Results
  • Melanoma
  • glembatumumab vedotin
  • +3 more
  • Los Angeles, California
  • +13 more
Sep 5, 2019

Lymphoma Trial in Germany, Poland, United States (Atezolizumab [TECENTRIQ], Obinutuzumab, Polatuzumab Vedotin)

Completed
Has Results
  • Lymphoma
  • Atezolizumab [TECENTRIQ]
  • +3 more
  • Los Angeles, California
  • +18 more
Nov 30, 2020

Myelodysplastic Syndrome, Multiple Myeloma, Hodgkin Lymphoma Trial (Pembrolizumab, Lenalidomide 20 mg, Lenalidomide 25 mg)

Completed
Has Results
  • Myelodysplastic Syndrome
  • +6 more
  • Pembrolizumab
  • +2 more
  • (no location specified)
Aug 2, 2021

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Canada, United States (brentuximab vedotin,

Completed
Has Results
  • Lymphoma, B-Cell
  • +3 more
  • Birmingham, Alabama
  • +33 more
Oct 14, 2016